Leroux-Roels, Geert

Genetic adaptation and Neandertal admixture shaped the immune system of human populations

Quach, H., Rotival, M., Pothlichet, J., Loh, Y.-H. E., Dannemann, M., Zidane, N., Laval, G., Patin, E., Harmant, C., Lopez, M., et al. (2016) · Cell

Genetic Associations and EpidemiologyEvolution and Genetic Dynamics

Cited by 475

Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial

Aldrich, C., Leroux–Roels, I., Huang, K. B., Bica, M. A., Loeliger, E., Schoenborn-Kellenberger, O., Walz, L., Leroux-Roels, G., von Sonnenburg, F., & Oostvogels, L. (2021) · Vaccine

Rabies epidemiology and controlRNA Interference and Gene Delivery

Cited by 204

Phase 1 Assessment of the Safety and Immunogenicity of an mRNA- Lipid Nanoparticle Vaccine Candidate Against SARS-CoV-2 in Human Volunteers

Kremsner, P., Mann, P., Bosch, J., Fendel, R., Gabor, J. J., Kreidenweiss, A., Kroidl, A., Leroux-Roels, I., Leroux-Roels, G., Schindler, C., et al. (2020) · Wiener klinische Wochenschrift

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies

Cited by 199

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

McElhaney, J. E., Beran, J., Devaster, J.-M., Esen, M., Launay, O., Leroux-Roels, G., Ruiz-Palacios, G. M., van Essen, G. A., Caplanusi, A., Claeys, C., et al. (2013) · The Lancet Infectious Diseases

Influenza Virus Research StudiesBacterial Infections and Vaccines

Cited by 164

A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults

Leroux-Roels, I., Leroux-Roels, G., Clement, F., Vandepapelière, P., Vassilev, V., Ledent, E., & Heineman, T. C. (2012) · The Journal of Infectious Diseases

Herpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus research

Cited by 147

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: Two clinical trials

De Coster, I., Leroux-Roels, I., Bandyopadhyay, A. S., Gast, C., Withanage, K., Steenackers, K., De Smedt, P., Aerssens, A., Leroux-Roels, G., Oberste, M. S., et al. (2021) · The Lancet

Viral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 Research

Cited by 86

Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection

de Vries, R. D., Nieuwkoop, N. J., Pronk, M., de Bruin, E., Leroux-Roels, G., Huijskens, E. G. W., van Binnendijk, R. S., Krammer, F., Koopmans, M. P. G., & Rimmelzwaan, G. F. (2017) · Vaccine

Influenza Virus Research StudiesMonoclonal and Polyclonal Antibodies Research

Cited by 63

Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50 years of age: Results from a phase III, randomized, non-inferiority trial

Ofori-Anyinam, O., Leroux-Roels, G., Drame, M., Aerssens, A., Maes, C., Amanullah, A., Schuind, A., Li, P., Jain, V. K., & Innis, B. L. (2017) · Vaccine

Influenza Virus Research StudiesPneumonia and Respiratory Infections

Cited by 31